Actively Recruiting
Evaluating Optical Coherence Tomography Imaging to Detect Bacteria or Biofilm in Open and Infected Fractures
Led by Dartmouth-Hitchcock Medical Center · Updated on 2026-10-02
40
Participants Needed
1
Research Sites
44 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are conducting a pilot prospective observational study to evaluate the feasibility and acceptability of Optical Coherence Tomography OCT, a light-based imaging method that does not require drugs or contrast agents. The study focuses on patients with open fractures or infected fractures, aiming to visualize bacteria or biofilm on hardware, bone, and soft tissue associated with these injuries. Participants include adults aged 18 years or older who have either a high-energy open fracture or an infected open or closed fracture. The study observes these patients using OCT imaging without administering any drugs or treatments, grouping them based on their fracture type to assess the imaging technologys use in these specific conditions. During the study, participants undergo OCT imaging to assess bacteria or biofilm presence. Researchers will measure how practical and acceptable this imaging method is over a 36-month period. No interventions beyond imaging are applied, and participants are observed to gather data related to fracture infection and healing. The total study duration extends until June 2027.
CONDITIONS
Brief Title
OCT in Open Fracture and Infected Fracture
Research Team
H
Holly B Symonds
D
Devin S Mullin
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here